Document 2756 DOCN M94A2756 TI Value of urinary HIV antibody in staging in patients with AIDS. DT 9412 AU Vardinon N; Yust I; Yavorkovsky E; Zeldis I; Stanescu R; Burke M; Tel Aviv Medical Center, Israel. SO Int Conf AIDS. 1994 Aug 7-12;10(1):231 (abstract no. PB0355). Unique Identifier : AIDSLINE ICA10/94369819 AB OBJECTIVE: In order to assess the diagnostic value of urine testing in HIV seropositive (SP) individuals, we examined urine and serum specimens in parallel to peripheral blood lymphocyte (PBL) populations from 74 HIV SP subjects. METHODS: Urine specimens were tested by EIA Abbott 3rd generation (3-G-EIA) and modified EIA (Mod-EIA). 156 seronegative subjects served as controls. Positive results were confirmed by Western blot (WB). For Mod-EIA, mouse antihuman IgG (Sigma) was substituted as the conjugate in the Abbott kit. PBL were monitored in a FACScan (BD) using monoclonal antibodies (Coulter) for T-cells CD3, CD4 and CD8. RESULTS: Sixty-nine out of 74 urine samples of SP individuals reacted in 3-G-EIA, whereas all 74 reacted in Mod-EIA. All five cases reacting as false negative urine samples in 3-G-EIA had CD4 counts higher than 900/mm2), CD4/CD8 ratio > 1 and indeterminate WB patterns with bands to gp160 or p24. The urine OD cut-off ratio in HIV SP subjects with CD4 counts above 700 was significantly lower than that of all other groups (p < 0.005). Sensitivity and specificity of Mod-EIA were 100% and 93.6% respectively. DISCUSSION AND CONCLUSION: Urinary antibody using Mod-EIA with 3-G-EIA is a simple highly sensitive and specific test for screening HIV infection and assessing early stages of HIV seroconversion. DE Acquired Immunodeficiency Syndrome/*DIAGNOSIS Comparative Study Evaluation Studies Human HIV Antibodies/BLOOD/*URINE HIV Infections/DIAGNOSIS/*URINE HIV Seropositivity/URINE Immunoenzyme Techniques Leukocyte Count Lymphocyte Subsets Sensitivity and Specificity MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).